Integrating in silico and in vivo approach for investigating the role of polyherbal oil in prevention and treatment of COVID-19 infection

Currently, there are no FDA approved antiviral drugs available to treat COVID-19 patients. Also, due to emergence of new SARS-CoV-2 variants, the protective efficacy of vaccines could be reduced, hence it is urgent to have alternative treatments for combating the SARS-CoV-2 infection. Since, there i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahl, Amul S., Verma, Vipin Kumar, Bhatia, Jagriti, Arya, Dharamvir Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472470/
https://www.ncbi.nlm.nih.gov/pubmed/36113631
http://dx.doi.org/10.1016/j.cbi.2022.110179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472470/
https://www.ncbi.nlm.nih.gov/pubmed/36113631
http://dx.doi.org/10.1016/j.cbi.2022.110179

Ejemplares similares